Biotech Stocks Pressured, Again (IBB)

Biotech stocks declined early on Thursday, with iShares Nasdaq Biotechnology ETF (Nasdaq: IBB) lower by about 3%. The group is down over 10% in the past month.

Notable decliners included popular stocks like Pharmacyclics Inc. (Nasdaq: PCYC), Gilead Sciences Inc. (Nasdaq: GILD), Biogen Idec Inc. (Nasdaq: BIIB) and Celgene Corporation (Nasdaq: CELG), to name a few.

You May Also Be Interested In

• Midday movers: Tesla, Blackstone, Las Vegas Sands fall; DR Horton rises
• Pfizer (PFE) drops to 11-year lows
• Duolingo (DUOL) to Join S&P MidCap 400; Cable One (CABO) to Join S&P SmallCap 600